Reports are out that a deputy director of the Division of Drug Risk Evaluation, part of the Office of Surveillance and Epidemiology (formerly the Office of Drug Safety) was reprimanded for recommending that the popular diabetes drug Avandia receive a “black Box” warning after taking her staffs advice.Rosemary Johann-Liang was on the verge of le
read more | digg story
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment